Vaxcyte, Inc. PCVX Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s change in accrued liabilities?
- Vaxcyte, Inc. (PCVX) reported change in accrued liabilities of -$15.57M in Q1 2026.
- How has Vaxcyte, Inc.'s change in accrued liabilities changed year-over-year?
- Vaxcyte, Inc.'s change in accrued liabilities decreased by 254.5% year-over-year, from -$4.39M to -$15.57M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.